Events

Conference: ACTIONABLE OCEAN SCIENCE 2024: The ocean we need for the future we want
NOV
Thu
14
09:30 - 12:00

This was 11 months ago

Location

Brussels

Rue Archimède 17, 1000 - Brussels
Programmes
Agro-Food, Environment Missions

On November 14, The Norwegian Institute of Marine Research welcomes you at the Norway House in Brussels to discuss the outlook and opportunities in marine research.

Here’s a summary of what to expect at this conference:

  • Learn about the latest advancements in Norwegian marine research and ocean management.
  • Gain insights into the European perspective on marine research and collaboration from Mr. Maris Stulgis of the EU.
  • Hear from project leaders involved in Mission Ocean and Waters-funded projects.

For more information and to register for this conference, please visit the dedicated page.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.